Apogee Therapeutics, Inc.APGENASDAQ
Loading
Cash & Equivalents Over TimeStable
Percentile Rank33
3Y CAGR-4.7%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-4.7%/yr
Annual compound
Percentile
P33
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
2025$131.55M-7.2%
2024$141.79M+19.8%
2023$118.32M-22.1%
2022$151.89M-